About PsyTrain NZ
How to become a psychedelic therapist in New Zealand
Interest in psychedelic-assisted therapy is growing fast, and so is the number of New Zealand clinicians wondering what a career in this space might look like. This guide sets out what we currently know about the pathways, the prerequisites, and what preparation actually makes a difference. This is a new and emerging field in Aotearoa, so it’s worth staying current if you’re planning to work with psychedelics.
The role of the prescriber vs. the facilitator
Psychedelic-assisted therapy typically involves two distinct professional roles, and New Zealand’s regulatory framework reflects this. Understanding which one you’re aiming for shapes everything about your training path.
The prescribing practitioner
Often a psychiatrist or medical doctor, holding the Regulation 22 approval from Medsafe. Responsible for clinical assessment, diagnosis, prescribing and medical oversight throughout treatment. Requires Medical Council of New Zealand registration, an appropriate Annual Practising Certificate, and specific experience with psychedelic medicines.
The facilitator
Works alongside the prescriber, providing the psychological support that makes treatment effective: preparing the patient, supporting them during the session, and facilitating integration afterward. The Medsafe treatment protocol guidelines explicitly require applicants to include “details of supporting clinical therapists,” so the facilitator role is built into the regulatory framework, even without prescribing authority.
Prerequisites by professional background
Psychiatrists & medical doctors
Best positioned to become an approved prescriber. You’ll need to demonstrate prior experience with psychedelic medicines, ideally research involvement or supervised clinical practice, and submit a detailed treatment protocol backed by peer review.
Psychologists, psychotherapists & clinical social workers
You can’t prescribe psilocybin, but the facilitator role fits your certifications well. A strong therapeutic background, ideally in trauma, existential distress, or end-of-life care, is highly relevant.
Nurses, OTs & allied health professionals
Allied health professionals with relevant mental health experience may be well suited to session support and integration roles, particularly as the field scales.
Counsellors & integration coaches
The current regulatory pathway is medically led, but counsellors and coaches with appropriate training are beginning to fill important roles, particularly in post-session integration work.
What good training looks like
Psychedelic therapy training isn’t yet formally standardised in New Zealand. Medsafe has indicated it wants practitioner teams with clinical experience, peer review, supervised practice, and knowledge of both the pharmacological and psychotherapeutic dimensions of treatment. High-quality programmes typically cover:
- Foundations: pharmacology, history of research, neurobiological mechanisms and therapeutic rationale
- Session skills: preparation, presence, non-directive support and navigating difficult experiences
- Ethics and context: professional boundaries, informed consent and cultural safety
- Clinical frameworks: screening, contraindications, set and setting, dosing protocols and safety monitoring
- Integration: helping clients gather meaning, somatic approaches and long-term follow-up
- Supervised practice: minimum supervised hours and mentoring before independent practice
New Zealand-specific training is beginning to emerge, including programmes designed for Kiwi time zones with NZ regulatory content. Australian programmes, many of which explicitly welcome New Zealand participants, are another option given how closely the two regulatory frameworks are now aligned.
Building your clinical foundation now
Training alone won’t get you approved to prescribe psilocybin, and it won’t make you a ready therapist overnight. Medsafe’s guidelines emphasise that clinical experience in relevant settings matters. Things you can do right now:
Deepen existing therapeutic skills, particularly in trauma, grief, anxiety and existential distress
Engage with integration therapy, supporting clients making meaning of experiences had elsewhere
Build relationships with practitioners already working in this space
Pursue clinical proficiency in ketamine-assisted therapy, where infrastructure is more established
Connect with research settings, as clinical trials remain an important route to supervised experience
Volunteer with organisations such as PsyCare Aotearoa for first-hand experience
Do you need personal experience?
It’s often asked whether you need personal psychedelic experience to work in this field. The honest answer is no — many skilled therapists have worked effectively in clinical trials without it.
Some programmes include experiential components, and many practitioners find personal experience enriches their clinical understanding. But this is a matter of professional discretion, not a hard credential.
Some programmes include experiential components, and many practitioners find personal experience enriches their clinical understanding. But this is a matter of professional discretion, not a hard credential.
The future of the field
New Zealand is in an early but genuinely promising position. As more practitioners build the experience required for Regulation 22 approval, the clinical infrastructure will grow around them.
Practitioners building knowledge and networks now will be positioned to lead that growth. That’s why training, even before the field is fully established, is an excellent investment.
Practitioners building knowledge and networks now will be positioned to lead that growth. That’s why training, even before the field is fully established, is an excellent investment.
Start building your foundation today
PsyTrain NZ is preparing future cohorts and new training partnerships to support Kiwis joining this emerging field. Join our mailing list to stay updated, or explore our current programmes.